Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC

Clinical Trial ID NCT02343952

PubWeight™ 2.49‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02343952

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Advances in immunotherapy for treatment of lung cancer. Cancer Biol Med 2015 0.95
2 PD-1/PD-L1 blockades in non-small-cell lung cancer therapy. Onco Targets Ther 2016 0.78
3 Results of clinical trials with anti-programmed death 1/programmed death ligand 1 inhibitors in lung cancer. Transl Lung Cancer Res 2015 0.78
Next 100